HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mitchell, R. S. Search for Related Content PubMed PubMed Citation Articles by Mitchell, R. S. Related Collections Great vessels

Ann Thorac Surg 2002;74:S1818-S1820
© 2002 The Society of Thoracic Surgeons

---

Session 2: Aortic and Endoluminal Stents

Stent grafts for the thoracic aorta: a new paradigm?

^a Department of Cardiovascular and Thoracic Surgery, Stanford University School of Medicine, Stanford, California, USA

* Address reprint requests to Dr Mitchell, Department of Cardiothoracic Surgery, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford CA, 94305-5247, USA
e-mail: rsmitch{at}stanford.edu

Presented at the Aortic Surgery Symposium VIII, May 2–3, 2002, New York, NY.

Abstract

The treatment of thoracic aortic pathology is complicated by the morbidity of the surgical procedure, and the comorbidities encountered in an elderly population. Stent grafts have now been used for approximately 10 years for the treatment of thoracic aneurysmal disease, management of aortic dissections, intramural hematoma, and giant penetrating ulcers, and for traumatic aortic tears, with impressive early results. However, these efforts have been significantly limited by the lack of a commercially available stent graft specifically designed for the thoracic aorta, the lack of real long-term follow-up, and the failure of experience in the abdominal aorta to translate to the thoracic aorta. Nevertheless, significant and even unique therapies have been enabled by stent graft technology for the treatment of the above-mentioned diseases. It is likely that, with more sophisticated technology and improved understanding of thoracic aortic pathology, stent graft use will expand, and its utility will be further clarified.

This article has been cited by other articles:

				S. D. Moffatt-Bruce and R. S. Mitchell Endovascular Therapy for the Treatment of Thoracic Aortic Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1299 - 1308. [Full Text]

				M. Doss, J. P. Wood, J. Balzer, S. Martens, H. Deschka, and A. Moritz Emergency endovascular interventions for acute thoracic aortic rupture: Four-year follow-up J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 645 - 651. [Abstract] [Full Text] [PDF]

				T. P. Carrel, P. A. Berdat, I. Baumgartner, H.-P. Dinkel, and J. Schmidli Combined Surgical and Endovascular Approach to Treat a Complex Aortic Coarctation Without Extracorporeal Circulation Ann. Thorac. Surg., October 1, 2004; 78(4): 1462 - 1465. [Abstract] [Full Text] [PDF]

				M. Doss, J. Balzer, S. Martens, J. P. Wood, G. Wimmer-Greinecker, H.-G. Fieguth, and A. Moritz Surgical versus endovascular treatment of acute thoracic aortic rupture: a single-center experience Ann. Thorac. Surg., November 1, 2003; 76(5): 1465 - 1470. [Abstract] [Full Text] [PDF]

				N. R. Tai and K. D Boffard Thoracic trauma: principles of early management Trauma, April 1, 2003; 5(2): 123 - 136. [Abstract] [PDF]